vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and EXPONENT INC (EXPO). Click either name above to swap in a different company.

Enact Holdings, Inc. is the larger business by last-quarter revenue ($312.7M vs $166.3M, roughly 1.9× EXPONENT INC). On growth, EXPONENT INC posted the faster year-over-year revenue change (14.3% vs 3.6%). Over the past eight quarters, EXPONENT INC's revenue compounded faster (8.8% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

ACT vs EXPO — Head-to-Head

Bigger by revenue
ACT
ACT
1.9× larger
ACT
$312.7M
$166.3M
EXPO
Growing faster (revenue YoY)
EXPO
EXPO
+10.7% gap
EXPO
14.3%
3.6%
ACT
Faster 2-yr revenue CAGR
EXPO
EXPO
Annualised
EXPO
8.8%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
ACT
ACT
EXPO
EXPO
Revenue
$312.7M
$166.3M
Net Profit
$29.6M
Gross Margin
Operating Margin
71.3%
24.9%
Net Margin
17.8%
Revenue YoY
3.6%
14.3%
Net Profit YoY
11.0%
EPS (diluted)
$1.23
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
EXPO
EXPO
Q1 26
$166.3M
Q4 25
$312.7M
$147.1M
Q3 25
$311.5M
$142.0M
Q2 25
$304.9M
$145.5M
Q1 25
$306.8M
$136.8M
Q4 24
$301.8M
Q3 24
$309.6M
$136.3M
Q2 24
$298.8M
$140.5M
Net Profit
ACT
ACT
EXPO
EXPO
Q1 26
$29.6M
Q4 25
$28.0M
Q3 25
$26.6M
Q2 25
$26.6M
Q1 25
$23.6M
Q4 24
Q3 24
$26.0M
Q2 24
$29.2M
Operating Margin
ACT
ACT
EXPO
EXPO
Q1 26
24.9%
Q4 25
71.3%
19.7%
Q3 25
67.4%
12.1%
Q2 25
70.4%
30.5%
Q1 25
68.9%
19.9%
Q4 24
68.9%
Q3 24
74.1%
19.0%
Q2 24
78.6%
25.4%
Net Margin
ACT
ACT
EXPO
EXPO
Q1 26
17.8%
Q4 25
19.1%
Q3 25
18.7%
Q2 25
18.3%
Q1 25
17.2%
Q4 24
Q3 24
19.1%
Q2 24
20.8%
EPS (diluted)
ACT
ACT
EXPO
EXPO
Q1 26
$0.59
Q4 25
$1.23
$0.55
Q3 25
$1.10
$0.52
Q2 25
$1.11
$0.52
Q1 25
$1.08
$0.45
Q4 24
$1.05
Q3 24
$1.15
$0.50
Q2 24
$1.16
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
EXPO
EXPO
Cash + ST InvestmentsLiquidity on hand
$582.5M
$118.6M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
$338.3M
Total Assets
$6.9B
$687.4M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
EXPO
EXPO
Q1 26
$118.6M
Q4 25
$582.5M
$207.4M
Q3 25
$545.6M
$231.8M
Q2 25
$616.0M
$245.1M
Q1 25
$639.0M
$258.9M
Q4 24
$602.8M
Q3 24
$674.9M
$219.7M
Q2 24
$711.3M
$203.3M
Total Debt
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
Stockholders' Equity
ACT
ACT
EXPO
EXPO
Q1 26
$338.3M
Q4 25
$5.4B
$402.9M
Q3 25
$5.3B
$427.8M
Q2 25
$5.2B
$441.4M
Q1 25
$5.1B
$421.1M
Q4 24
$5.0B
Q3 24
$5.0B
$410.3M
Q2 24
$4.8B
$393.2M
Total Assets
ACT
ACT
EXPO
EXPO
Q1 26
$687.4M
Q4 25
$6.9B
$761.4M
Q3 25
$6.9B
$759.4M
Q2 25
$6.8B
$763.2M
Q1 25
$6.7B
$777.3M
Q4 24
$6.5B
Q3 24
$6.6B
$744.1M
Q2 24
$6.3B
$709.2M
Debt / Equity
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
EXPO
EXPO
Operating Cash FlowLast quarter
$724.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
$724.5M
$32.7M
Q3 25
$192.0M
$36.2M
Q2 25
$119.5M
$7.3M
Q1 25
$226.7M
$56.1M
Q4 24
$686.3M
Q3 24
$188.1M
$29.7M
Q2 24
$144.7M
$48.3M
Free Cash Flow
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
$30.0M
Q3 25
$33.9M
Q2 25
$5.5M
Q1 25
$53.5M
Q4 24
Q3 24
$28.0M
Q2 24
$47.2M
FCF Margin
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
20.4%
Q3 25
23.9%
Q2 25
3.8%
Q1 25
39.1%
Q4 24
Q3 24
20.5%
Q2 24
33.6%
Capex Intensity
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
1.8%
Q3 25
1.6%
Q2 25
1.2%
Q1 25
1.9%
Q4 24
Q3 24
1.3%
Q2 24
0.8%
Cash Conversion
ACT
ACT
EXPO
EXPO
Q1 26
Q4 25
1.16×
Q3 25
1.36×
Q2 25
0.27×
Q1 25
2.38×
Q4 24
Q3 24
1.14×
Q2 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACT
ACT

Segment breakdown not available.

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

Related Comparisons